Overview

  • Product name
    Anti-MCP4 antibody [500-M70]
    See all MCP4 primary antibodies
  • Description
    Mouse monoclonal [500-M70] to MCP4
  • Tested applications
    Suitable for: ELISA, Neutralisingmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Highly pure (>98%) recombinant hMCP-4 (human Macrophage/Monocyte chemotactic protein-4).

Properties

  • Form
    Lyophilised:Reconstitute with 500µl of sterile water.
  • Storage instructions
    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
  • Storage buffer
    PBS, pH 7.4, no preservative, sterile filtered
  • Concentration information loading...
  • Purity
    Protein A purified
  • Clonality
    Monoclonal
  • Clone number
    500-M70
  • Myeloma
    unknown
  • Isotype
    IgG1
  • Light chain type
    unknown
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab9559 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA
Neutralising
  • Application notes
    NEUTRALIZATION:To yield one-half maximal inhibition [ND50] of the biological activity of rMCP-4 (100ng/ml), a concentration of 1-5µg/ml of the antibody is required.

    ELISA:This antibody can be used at a concentration of 1-2µg/ml, as a capture antibody in conjunction with a compatible secondary reagent to yield satisfactory results in a sandwich ELISA (using 100µl/well antibody solution).
  • Target

    • Function
      Chemotactic factor that attracts monocytes, lymphocytes, basophils and eosinophils, but not neutrophils. Signals through CCR2B and CCR3 receptors. Plays a role in the accumulation of leukocytes at both sides of allergic and non-allergic inflammation. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis. May play a role in the monocyte attraction in tissues chronically exposed to exogenous pathogens.
    • Tissue specificity
      Widely expressed. Found in small intestine, thymus, colon, lung, trachea, stomach and lymph node. Low levels seen in the pulmonary artery smooth muscle cells.
    • Sequence similarities
      Belongs to the intercrine beta (chemokine CC) family.
    • Post-translational
      modifications
      One major form (form long), and two minor forms (short chain and medium chain) are produced by differential signal peptide cleavage. The medium chain is about 30-fold less active than the long chain.
    • Cellular localization
      Secreted.
    • Information by UniProt
    • Database links
    • Alternative names
      • C-C motif chemokine 13 antibody
      • CCL13 antibody
      • CCL13_HUMAN antibody
      • Chemokine (C C motif) ligand 13 antibody
      • CK beta 10 antibody
      • CK-beta-10 antibody
      • CKb10 antibody
      • MCP-4 antibody
      • MGC17134 antibody
      • Monocyte chemoattractant protein 4 antibody
      • Monocyte chemotactic protein 4 antibody
      • NCC 1 antibody
      • NCC-1 antibody
      • NCC1 antibody
      • New CC chemokine 1 antibody
      • SCYA13 antibody
      • SCYL1 antibody
      • short chain antibody
      • Small inducible cytokine A13 precursor antibody
      • Small inducible cytokine subfamily A (Cys Cys) member 13 antibody
      • Small-inducible cytokine A13 antibody
      see all

    References for Anti-MCP4 antibody [500-M70] (ab9559)

    This product has been referenced in:
    • Martin P  et al. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am J Pathol 179:422-35 (2011). Read more (PubMed: 21703421) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab9559.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up